CSG Shares: A Market Disconnect Amid Record Performance

CSG posts record 2025 revenue and a €42B backlog, yet its stock has fallen ~19%. Analysts cite portfolio rebalancing and budget fears, but see a buying chance.

Despite posting record-breaking financial results and enjoying unanimous buy recommendations from analysts, shares of CSG N.V. have experienced a significant pullback. This divergence between the company's operational strength and its stock price performance has become a focal point for investor discussion.

Record Financials and a Robust Backlog

The foundation for the prevailing analyst optimism was laid with the 2025 annual results, released on March 26. Revenue surged by 71.7% to €6.7 billion, a jump fueled by demand for artillery systems and ammunition, alongside the integration of The Kinetic Group. Adjusted operating EBIT increased 60.7% to €1.6 billion, yielding a margin of 24.1%. Net profit from continuing operations grew 35.5% to €872 million.

Crucially for its medium-term outlook, CSG's order backlog swelled to €15 billion, with an additional pipeline of €27 billion. This combined €42 billion in visibility, up from €32 billion previously, provides substantial revenue certainty for years to come.

In a significant vote of confidence for its financial health, Moody's upgraded CSG's secured debt rating from Ba1 to Baa3 in February 2026—moving it from speculative to investment-grade status. Fitch Ratings affirmed its BBB- rating with a stable outlook. Both decisions reflect the company's improved governance and a more conservative financial strategy.

Explaining the Share Price Decline

Even with these strong fundamentals, the stock has traded approximately 19% below its all-time high of €35.50, reached on January 26, 2026. It subsequently touched a post-IPO low of €26.74 on March 20, 2026. Since the escalation of the US/Israel-Iran conflict, CSG has lost about 19% of its value, underperforming the average 8% decline seen across the European defense sector.

JPMorgan analyst David Perry identifies three primary factors behind this weakness: portfolio rebalancing by institutional investors, concerns that rising sovereign debt could crowd out future defense budgets, and growing market skepticism regarding execution risks at rapidly expanding companies. Paradoxically, JPMorgan views this sell-off as a buying opportunity, suggesting investors use the sector-wide pullback to build positions.

Strategic Expansion and Conservative Guidance

CSG is actively broadening its strategic footprint. In March 2026, the company announced a 49% stake in 4iG Space & Defence Technologies. The deal includes contracts for military vehicle production and potential involvement in a HIMARS program for Hungary. Furthermore, CSG signed a framework agreement with Polish defense group PGZ to develop propulsion systems for unmanned platforms and missiles.

Looking ahead, management forecasts 2026 revenue between €7.4 and €7.6 billion, with an adjusted EBIT margin of 24% to 25%. The medium-term target is for organic annual revenue growth in the mid-teens percentage range, with margins expanding to 26-28%.

JPMorgan notes that the company's debt guidance appears exceptionally conservative. While CSG aims for a net debt-to-EBITDA ratio below 1.5x by the end of 2026, the bank estimates the actual figure could be around 0.7x. This calculation factors in the €750 million raised during the IPO and an expected free cash flow of €800 to €900 million for the current year.

The average analyst price target for CSG stands at €35.83. The market will get its next clue on whether this assessment is justified when the company reports its Q1 figures on May 20, 2026.